CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-20 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −5,000 | $36.40 | $182K | 53,007 |
| 2023-11-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +5,000 | 32,604 | ||
| 2023-11-15 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −200 | $38.00 | $8K | 33,195 |
| 2023-11-15 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −100 | $38.06 | $4K | 33,095 |
| 2023-11-15 | Flynn Sean C. SVP, General Counsel | Gift | −1,042 | 6,005 | ||
| 2023-11-15 | SIEGAL JONATHAN Principal Accounting Officer | Sale | −662 | $37.70 | $25K | 1,305 |
| 2023-10-02 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise | +938 | 2,134 | ||
| 2023-10-02 | SIEGAL JONATHAN Principal Accounting Officer | Shares withheld for taxes | −276 | $33.19 | $9K | 1,858 |
| 2023-10-02 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Restricted Stock Unit | +938 | 1,875 | ||
| 2023-08-04 | Halpin Michael Chief Operating Officer | Gift | −16,359 | 684 | ||
| 2023-08-04 | Halpin Michael Chief Operating Officer | Gift | +16,359 | 16,359 | ||
| 2023-07-14 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −1,000 | $38.84 | $39K | 33,395 |
| 2023-06-22 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −3,000 | $36.00 | $108K | 34,395 |
| 2023-06-01 | WRIGHT LISA Director | Option exercise | +433 | 5,817 | ||
| 2023-06-01 | WRIGHT LISA Director | Option exercise · Restricted Stock Unit | −433 | 434 | ||
| 2023-05-03 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2023-05-03 | MCLAUGHLIN KEVIN F Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2023-05-03 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2023-05-03 | ZERBE ROBERT L MD Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2023-05-03 | Hagen Heidi Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 |
Page 35 of 75 · 1,497 trades